Generali Investments Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$619K Hold
3,178
0.13% 97
2026
Q1
$713K Buy
3,178
+1,420
+81% +$354K 0.17% 96
2025
Q4
$423K Buy
1,758
+450
+34% +$115K 0.08% 110
2025
Q3
$358K Buy
+1,308
New +$357K 0.07% 123

Other funds holding RMD

Generali Investments Management's RMD Position: Q2 2026 in Review

Generali Investments Management held its ResMed (RMD) position steady in Q2 2026 at 3,178 shares worth $619K. The position accounts for 0.13% of the portfolio, ranked #97.

Generali Investments Management first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $713K in Q1 2026. 142 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Generali Investments Management held 3,178 shares of ResMed worth $619K as of Q2 2026.
  • Generali Investments Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.13% of Generali Investments Management's portfolio in Q2 2026, its #97 holding.
  • Generali Investments Management first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • Generali Investments Management's ResMed position peaked at $713K in Q1 2026.
  • 142 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.